Pioglitazone inhibits angiotensin II-induced atrial fibroblasts proliferation via NF-κB/TGF-β1/TRIF/TRAF6 pathway

Exp Cell Res. 2015 Jan 1;330(1):43-55. doi: 10.1016/j.yexcr.2014.08.021. Epub 2014 Aug 23.

Abstract

The exact mechanisms underlying inhibitory effects of pioglitazone (Pio) on Angiotensin II (AngII)-induced atrial fibrosis are complex and remain largely unknown. In the present study, we examined the effect of Pio on AngII-induced mice atrial fibrosis in vivo and atrial fibroblasts proliferation in vitro. In vivo study showed that AngII infusion induced atrial fibrosis and increased expressions of Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) and tumor necrosis factor receptor associated factor 6 (TRAF6) in mice models. However, those effects could be attenuated by Pio (P<0.01). As for in vitro experiment, Pio suppressed AngII-induced atrial fibroblasts proliferation via nuclear factor-κB/transforming growth factor-β1/TRIF/TRAF6 signaling pathway in primary cultured mice atrial fibroblasts (P<0.01). In conclusion, suppression of Pio on AngII-induced atrial fibrosis might be related to its inhibitory effects on above signaling pathway.

Keywords: Angiotensin II; Atrial fibrosis; Pioglitazone; Signaling pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Vesicular Transport / metabolism
  • Angiotensin II / pharmacology*
  • Animals
  • Cell Proliferation*
  • Fibrosis / metabolism
  • Heart Atria / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Myofibroblasts / drug effects
  • Myofibroblasts / metabolism*
  • Myofibroblasts / physiology
  • NF-kappa B / metabolism
  • Pioglitazone
  • Signal Transduction*
  • TNF Receptor-Associated Factor 6 / metabolism
  • Thiazolidinediones / pharmacology*
  • Transforming Growth Factor beta1 / metabolism

Substances

  • Adaptor Proteins, Vesicular Transport
  • NF-kappa B
  • TICAM-1 protein, mouse
  • TNF Receptor-Associated Factor 6
  • Thiazolidinediones
  • Transforming Growth Factor beta1
  • Angiotensin II
  • Pioglitazone